1H-Pyrrolo[3,4-c]pyridin-3(2H)-one

1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Suppliers list
Company Name: EnliPharma Technology Co., Ltd  
Tel: 0551-66399836 18955197623
Email: sales@enlipharma.com
Company Name: Shanghai Carlow Chemicals Co., Ltd.  
Tel: 21-33526724 18930996265
Email: info@carlowchem.com
Company Name: JW & Y Pharmlab Co., Ltd.  
Tel: 021-64340559
Email: xinyu_shi@jwypharmlab.com.cn
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: BioPharmaMatrix,Inc.  
Tel: 0510-86010668 13395169561;
Email: sales@biopharmamatrix.com
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Basic information
Product Name:1H-Pyrrolo[3,4-c]pyridin-3(2H)-one
Synonyms:1H-Pyrrolo[3,4-c]pyridin-3(2H)-one;1,2-Dihydro-3H-pyrrolo[3,...;1,2-Dihydro-3H-pyrrolo[3,4-c]pyridin-3-one;3H-Pyrrolo[3,4-c]pyridin-3-one, 1,2-dihydro-;1. 1,2-Dihydro-3H-pyrrolo[3,4-c]pyridin-3-one;1H,2H,3H-pyrrolo[3,4-c]pyridin-3-one;1,2-dihydropyrrolo[3,4-c]pyridin-3-one;1H-Pyrrolo[3,4-c]pyridin-3(2H)
CAS:40107-95-7
MF:C7H6N2O
MW:134.14
EINECS:
Product Categories:
Mol File:40107-95-7.mol
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Structure
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Chemical Properties
Boiling point 407.0±34.0 °C(Predicted)
density 1.286±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
pka12.37±0.20(Predicted)
AppearanceYellow to brown Solid
InChIInChI=1S/C7H6N2O/c10-7-6-4-8-2-1-5(6)3-9-7/h1-2,4H,3H2,(H,9,10)
InChIKeyROSODFDWJFAKQI-UHFFFAOYSA-N
SMILESC1=NC=CC2CNC(=O)C1=2
Safety Information
MSDS Information
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Usage And Synthesis
Synthesis
3,4-PYRIDINEDICARBOXIMIDE

4664-01-1

1H-Pyrrolo[3,4-c]pyridin-3(2H)-one

40107-95-7

General procedure: 3,4-pyridinedicarboximide (0.40 g, 2.7 mmol, 1.0 eq.) was dissolved in acetic acid (12 mL) and zinc powder (0.78 g, 11.9 mmol, 4.4 eq.) was added. The suspension was heated to reflux for 24 hours. After completion of the reaction, it was cooled to room temperature and the mixture was filtered through a diatomaceous earth pad. The filtrate was concentrated under reduced pressure and the residue was dissolved in dichloromethane (CH2Cl2). Anhydrous calcium chloride (CaCl2) was added to this solution and the insoluble material was removed by filtration. The filtrate was concentrated again under reduced pressure and the resulting crude product was purified by column chromatography using ethyl acetate/methanol (95:5, v/v) as eluent. The target fraction was collected, concentrated and crystallized from ethanol to give 1H-pyrrolo[3,4-c]pyridin-3(2H)-one (0.061 g, 17% yield) as a yellow solid. Product characterization: melting point 190-193 °C (decomposition); 1H NMR (300 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.70 (br d, 2H), 7.62 (d, J = 5.5 Hz, 1H), 4.42 (s, 2H); 13C NMR (75 MHz, DMSO-d6) δ 169.1, 153.3 , 151.6, 145.3, 129.0, 119.9, 45.2; GC-MS m/z 134 (M+); IR (KBr) 2856, 1728, 1692, 1455, 1206, 1026 cm-1. Calculated elemental values (C7H6N2O): C, 62.68; H, 4.51; N, 20.88. measured values Calculated values for elemental analysis (C7H6N2O): C, 62.68; H, 4.51; N, 20.88.

References[1] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 58 - 66,9
[2] Patent: WO2005/103003, 2005, A2. Location in patent: Page/Page column 106
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one Preparation Products And Raw materials
Raw materials3,4-Pyridinedicarboximide-->Dichloromethane-->Calcium chloride
Tag:1H-Pyrrolo[3,4-c]pyridin-3(2H)-one(40107-95-7) Related Product Information